Business · 1 sources covering this

Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside

The brokerage expects revenues to clock a compound annual growth rate of 62% over FY26FY28E, driven by store additions, improved operations and continued network scale-up.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside
The brokerage expects revenues to clock a compound annual growth rate of 62% over FY26FY28E, driven by store additions, improved operations and continued network scale-up.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/9dbfede8b7b15545cfeec219dcdd3cc9019f1f5f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside"></iframe>

Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside

How 1 sources are covering this

Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside

More from Business

Tata Sons debate: Listed middle layer NBFCs have higher advances as NPAs

CBSE drops three subjects from curriculum for Class 10 board batch 2028

GSLV-F18/NVS-03 Mission launch today: Check time, how to watch LIVE | All about 2nd gen NavIC series; 20th GSLV flight

Mumbai's coastal edge fades as air pollution levels surge sharply

Reader

Trust & legal

Across the network